Monoclonal antibodies (mAbs), highly specific binding proteins produced within the immune system in response to foreign antigens, seem to be an increasingly valuable commodity within pharmaceutical portfolios. With big-name successes...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)